| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR SER TR | 300,000 | 17,757,000 | 14.15% | Call | |
| 2 | SPDR SER TR | 130,000 | 7,695,000 | 6.13% | ||
| 3 | ISHARES TR | 25,000 | 6,635,000 | 5.29% | ||
| 4 | BRISTOL MYERS SQUIBB CO | 90,000 | 5,260,000 | 4.19% | ||
| 5 | MERCK & CO INC | 83,700 | 4,927,000 | 3.93% | ||
| 6 | ALKERMES PLC SHS | 82,296 | 4,574,000 | 3.64% | ||
| 7 | IONIS PHARMACEUTICALS INC | 77,550 | 3,709,000 | 2.95% | ||
| 8 | PFIZER INC | 112,300 | 3,648,000 | 2.91% | ||
| 9 | SEATTLE GENETICS INC | 68,310 | 3,605,000 | 2.87% | ||
| 10 | INCYTE | 35,031 | 3,513,000 | 2.80% | ||
| 11 | PROSHARES TR | 85,000 | 3,392,000 | 2.70% | ||
| 12 | ALNYLAM PHARMACEUTICALS INC | 88,784 | 3,324,000 | 2.65% | ||
| 13 | ASTRAZENECA PLC | 120,000 | 3,278,000 | 2.61% | ||
| 14 | CELGENE CORP | 27,286 | 3,158,000 | 2.52% | ||
| 15 | QIAGEN NV | 111,683 | 3,129,000 | 2.49% | ||
| 16 | BIOGEN INC | 10,872 | 3,083,000 | 2.46% | ||
| 17 | ALEXION PHARMACEUTIC | 24,973 | 3,055,000 | 2.43% | ||
| 18 | METTLER-TOLEDO | 7,188 | 3,009,000 | 2.40% | ||
| 19 | REGENERON PHARMACEUTICALS | 7,684 | 2,821,000 | 2.25% | ||
| 20 | AMGEN INC | 18,743 | 2,740,000 | 2.18% | ||
| 21 | BRISTOL MYERS SQUIBB CO | 45,000 | 2,630,000 | 2.10% | Call | |
| 22 | BIOMARIN | 31,579 | 2,616,000 | 2.08% | ||
| 23 | VERTEX PHARMACEUT | 33,357 | 2,457,000 | 1.96% | ||
| 24 | ILLUMINA INC | 18,967 | 2,429,000 | 1.94% | ||
| 25 | AGIOS PHARMACEUTICALS INC | 55,524 | 2,317,000 | 1.85% | ||
| 26 | GLAXOSMITHKLINE PLC | 60,000 | 2,311,000 | 1.84% | ||
| 27 | NEKTAR THERAPEUTICS COM | 184,328 | 2,262,000 | 1.80% | ||
| 28 | PACIRA BIOSCIENCES INC | 50,000 | 1,615,000 | 1.29% | ||
| 29 | TESARO INC | 10,000 | 1,345,000 | 1.07% | ||
| 30 | CLOVIS ONCOLOGY INC | 30,000 | 1,333,000 | 1.06% | ||
| 31 | PARATEK PHARMACEUTICALS INC | 80,000 | 1,232,000 | 0.98% | ||
| 32 | LILLY ELI & CO | 15,000 | 1,103,000 | 0.88% | Call | |
| 33 | ADAMAS PHARMACEUTICALS INC | 60,000 | 1,014,000 | 0.81% | ||
| 34 | MEDICINES CO | 28,000 | 950,000 | 0.76% | ||
| 35 | NEW SR INVEST GRP INC COM | 83,700 | 819,000 | 0.65% | ||
| 36 | ULTRAGENYX PHARMACEUTICAL INC COM | 10,864 | 764,000 | 0.61% | ||
| 37 | PORTOLA PHARMACEUTICALS INC | 25,000 | 561,000 | 0.45% | ||
| 38 | CONTRAFECT CORP COM | 300,000 | 525,000 | 0.42% | ||
| 39 | DIREXION DAILY S&P BIOTECH BULL 3X SHARES | 14,300 | 448,000 | 0.36% | ||
| 40 | SOCIETAL CDMO INC | 40,000 | 322,000 | 0.26% | ||
| 41 | ACADIA PHARMACEUTICALS INC COM | 10,042 | 290,000 | 0.23% | ||
| 42 | UNITED THERAPEUTICS | 1,951 | 280,000 | 0.22% | ||
| 43 | Lion Biotechnologies | 38,947 | 271,000 | 0.22% | ||
| 44 | GRIFOLS S A SP ADR REP B | 16,613 | 267,000 | 0.21% | ||
| 45 | LIGAND PHARMACEUTICALS INC | 2,589 | 263,000 | 0.21% | ||
| 46 | QUINTILES IMS HOLDINGS INC | 3,418 | 260,000 | 0.21% | ||
| 47 | BIO TECHNE CORP | 2,467 | 254,000 | 0.20% | ||
| 48 | CHARLES RIV LABS INTL INC | 3,303 | 252,000 | 0.20% | ||
| 49 | GILEAD SCIENCES INC | 3,408 | 244,000 | 0.19% | ||
| 50 | KITE PHARMA INCORPORATED | 5,367 | 241,000 | 0.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-17-000802, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
